We are live on ! Find out more
GI

GAMMA Investing Portfolio holdings

AUM $2.69B
1-Year Est. Return 42.78%
This Fund
S&P 500
This Quarter Est. Return
+4.14%
1 Year Est. Return
+42.78%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.99B
AUM Growth
+$177M
Cap. Flow
+$136M
Cap. Flow %
6.83%
Top 10 Hldgs %
28.11%
Holding
4,203
New
330
Increased
2,288
Reduced
1,042
Closed
109

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$10.4M
2
NVDA icon
NVIDIA
NVDA
+$6.62M
3
MSFT icon
Microsoft
MSFT
+$5.14M
4
EWC icon
iShares MSCI Canada ETF
EWC
+$4.46M
5
LLY icon
Eli Lilly
LLY
+$4.44M

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$2.05M
2
GE icon
GE Aerospace
GE
+$1.19M
3
LIN icon
Linde
LIN
+$955K
4
K
Kellanova
K
+$804K
5
KMB icon
Kimberly-Clark
KMB
+$781K

Sector Composition

Rank Sector Weight
1 Technology 27.22%
2 Financials 12.87%
3 Consumer Discretionary 9.03%
4 Healthcare 8.77%
5 Industrials 8.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WINA icon
2901
Winmark
WINA
$1.32B
$4.86K ﹤0.01%
12
-2
-14% -$856
RPAY icon
2902
Repay Holdings
RPAY
$317M
$4.86K ﹤0.01%
1,331
+1,175
+753% +$4.71K
LFCR icon
2903
Lifecore Biomedical
LFCR
$184M
$4.85K ﹤0.01%
593
+81
+16% +$599
ZUMZ icon
2904
Zumiez
ZUMZ
$343M
$4.84K ﹤0.01%
186
+13
+8% +$312
LE icon
2905
Lands' End
LE
$406M
$4.83K ﹤0.01%
333
SMBK icon
2906
SmartFinancial
SMBK
$877M
$4.81K ﹤0.01%
130
-9
-6% -$326
REPL icon
2907
Replimune Group
REPL
$1.16B
$4.8K ﹤0.01%
494
-33
-6% -$281
IDR icon
2908
Idaho Strategic Resources
IDR
$553M
$4.8K ﹤0.01%
119
+32
+37% +$1.22K
KURA icon
2909
Kura Oncology
KURA
$853M
$4.75K ﹤0.01%
457
+340
+291% +$3.57K
MITK icon
2910
Mitek Systems
MITK
$816M
$4.75K ﹤0.01%
450
+14
+3% +$132
TCMD icon
2911
Tactile Systems Technology
TCMD
$662M
$4.73K ﹤0.01%
163
+87
+114% +$1.93K
TSBK icon
2912
Timberland Bancorp
TSBK
$351M
$4.73K ﹤0.01%
132
+9
+7% +$304
DH icon
2913
Definitive Healthcare
DH
$74.6M
$4.72K ﹤0.01%
1,645
+1,637
+20,463% +$4.54K
CHCT
2914
Community Healthcare Trust
CHCT
$434M
$4.71K ﹤0.01%
287
+108
+60% +$1.61K
ALKT icon
2915
Alkami Technology
ALKT
$2.09B
$4.71K ﹤0.01%
204
-154
-43% -$3.4K
JMSB icon
2916
John Marshall Bancorp
JMSB
$326M
$4.7K ﹤0.01%
235
MAMA icon
2917
Mama's Creations
MAMA
$820M
$4.68K ﹤0.01%
347
+68
+24% +$781
XRX icon
2918
Xerox
XRX
$424M
$4.66K ﹤0.01%
1,967
+627
+47% +$1.86K
AGIO icon
2919
Agios Pharmaceuticals
AGIO
$1.94B
$4.66K ﹤0.01%
171
-35
-17% -$1.23K
CRWV
2920
CoreWeave
CRWV
$49.2B
$4.66K ﹤0.01%
65
+54
+491% +$5.47K
LUNG icon
2921
Pulmonx
LUNG
$96.6M
$4.65K ﹤0.01%
+2,105
New +$3.96K
GRPN icon
2922
Groupon
GRPN
$945M
$4.65K ﹤0.01%
264
-52
-16% -$979
MFC icon
2923
Manulife Financial
MFC
$73.5B
$4.64K ﹤0.01%
128
CAC icon
2924
Camden National
CAC
$966M
$4.64K ﹤0.01%
107
-6
-5% -$242
NWL icon
2925
Newell Brands
NWL
$2.52B
$4.63K ﹤0.01%
1,245
-7,354
-86% -$29.7K

Similar funds

GAMMA Investing's Q4 2025 Portfolio in Review

As of Q4 2025, GAMMA Investing held 4,203 positions worth $1.99B, up 9.8% from $1.81B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

GAMMA Investing deployed $136M of net new capital in Q4 2025, opening 330 new positions and adding to 2,288 existing holdings. Its largest new stake was iShares MSCI Canada ETF: 86,202 shares worth $4.65M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was JPMorgan Chase, an estimated $2.05M trimmed.

  • GAMMA Investing's largest Q4 2025 buy was iShares MSCI Canada ETF: 86,202 shares worth $4.65M.
  • GAMMA Investing added most to Apple in Q4 2025, an estimated $10.4M increase.
  • GAMMA Investing's biggest Q4 2025 reduction was JPMorgan Chase, cutting an estimated $2.05M.
  • GAMMA Investing fully exited Kellanova in Q4 2025, selling an estimated $804K.
  • GAMMA Investing's ten largest holdings make up 28% of its $1.99B portfolio in Q4 2025.
  • GAMMA Investing opened 330 new positions and closed 109 in Q4 2025.
  • GAMMA Investing's portfolio value rose 9.8% quarter-over-quarter to $1.99B.

Based on GAMMA Investing's 13F filing for Q4 2025, filed 5 Jan 2026.